
October 13, 2026 FDA, Female Sexual Disorders, specialty pharmaceuticals, women's health
Netherlands-based clinical-stage biopharmaceutical company developing innovative therapies for women with Female Sexual Disorders (FSD), Arletta Pharma Solutions has appointed Jeannette …

October 12, 2026 CDMO, clinical trials, pharmaceutical markets
Symbiosis Pharmaceutical Services has further strengthened its commercial team with three new appointments. Payal Roychoudhury and JoaquÃn Pérez Fornieles join …

September 28, 2026 Alcami
Alcami has appointed Will Isom as Vice President of Laboratory Services Sales, creating a new commercial role focused on its …

September 21, 2026 Codis
Codis has appointed Steven Facer as Chief Commercial Officer (CCO) in a newly created role as the contract development and …

September 14, 2026 FibroFind
FibroFind, a preclinical Contract Research Organization (CRO) specialising in human-relevant tissue models, has appointed Professor Andrew Fisher as Chief Medical …

September 2, 2026 Alex Jones, Cytomos, non-executive director
Edinburgh-based biotechnology company Cytomos has appointed life sciences executive Dr Alex Jones as a non-executive director as it moves to …

August 25, 2026 Made Smarter, North West team
Made Smarter has appointed four specialists to its North West team as increasing numbers of SME manufacturers seek support with …

August 3, 2026 Syntis Bio
Syntis Bio has appointed Matthew Dallas as Chief Financial Officer (CFO). Dallas brings more than 25 years of financial expertise …

July 28, 2026 Simris Group
Simris Group has appointed Tiffany J Vora as a Strategic Advisor. This follows the recent appointment of Andreas Pahl as …

July 21, 2026 FibroFind
FibroFind, a preclinical Contract Research Organisation has appointed Lee Borthwick as CEO, as the company begins its next phase of …